Search in:

Advanced search

International Journal of Chronic Obstructive Pulmonary Disease Volume 12, 2017 - Issue

Submit an article Journal homepage

Open access

106

Views

CrossRef citations to date

Altmetric

Original Research

Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist

Hsi-Hsing Yang1 Department of Intensive Care Medicine, Chi Mei Medical Center, Tainan;2 Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan

Chih-Cheng Lai3 Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Tainan

Ya-Hui Wang4 Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu-Jen Catholic University, New Taipei City

Wei-Chih Yang5 Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Miaoli County

Cheng-Yi Wang4 Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu-Jen Catholic University, New Taipei CityCorrespondence[email protected]

Hao-Chien Wang6 Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, TaiwanCorrespondence[email protected]

Likwang Chen5 Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Miaoli County

Chong-Jen Yu6 Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan

show all

Pages 2477-2485 | Published online: 21 Aug 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

Global Initiative for Chronic Obstructive Lung DiseasesGlobal Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary DiseaseVancouver, WAGlobal Initiative for Chronic Obstructive Lung Disease (GOLD)2014
Google Scholar
World Health ReportGenevaWorld Health Organization2000 Available from: http://www.who.int/whr/2000/en/statistics.htmAccessed July 1, 2016
Google Scholar
MathersCDLoncarDProjections of global mortality and burden of diseases from 2002 to 2030PLoS Med2006311e44217132052
PubMed Web of Science ®Google Scholar
SuissaSDell’AnielloSErnstPLong-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortalityThorax2012671195796322684094
PubMed Web of Science ®Google Scholar
de MeloMNErnstPSuissaSInhaled corticosteroids and the risk of a first exacerbation in COPD patientsEur Respir J200423569269715176681
PubMed Web of Science ®Google Scholar
BourbeauJErnstPCockcoftDSuissaSInhaled corticosteroids and hospitalisation due to exacerbation of COPDEur Respir J200322228628912952262
PubMed Web of Science ®Google Scholar
SuissaSNumber needed to treat in COPD: exacerbations versus pneumoniasThorax201368654054323125170
PubMed Web of Science ®Google Scholar
de MeloMNErnstPSuissaSRates and patterns of chronic obstructive pulmonary disease exacerbationsCan Respir J200411855956415611805
PubMedGoogle Scholar
CalverleyPPauwelsRVestboJTRial of Inhaled STeroids ANd long-acting beta2 agonists study groupCombined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialLancet2003361935644945612583942
PubMed Web of Science ®Google Scholar
CalverleyPMAndersonJACelliBTORCH investigatorsSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
PubMed Web of Science ®Google Scholar
CalverleyPMBoonsawatWCsekeZMaintenance therapy with budesonide and formoterol in chronic obstructive pulmonary diseaseEur Respir J200322691291914680078
PubMed Web of Science ®Google Scholar
SzafranskiWCukierARamirezAEfficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J2003211748112570112
PubMed Web of Science ®Google Scholar
JansonCLarssonKLisspersKHPneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS)BMJ2013346f330623719639
PubMed Web of Science ®Google Scholar
WangCYLaiCCYangWCThe association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) studyInt J Chron Obstruct Pulmon Dis2016112775278327877031
PubMed Web of Science ®Google Scholar
LarssonKJansonCLisspersKCombination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS studyJ Intern Med2013273658459423495860
PubMed Web of Science ®Google Scholar
HastieTTibshiraniRExploring the nature of covariate effects in the proportional hazards modelBiometrics1990464100510161964808
PubMed Web of Science ®Google Scholar
BlaisLForgetARamachandranSRelative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherenceClin Ther20103271320132820678680
PubMed Web of Science ®Google Scholar
TashkinDPRennardSIMartinPEfficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trialDrugs200868141975200018778120
PubMed Web of Science ®Google Scholar
RennardSITashkinDPMcElhattanJEfficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trialDrugs200969554956519368417
PubMed Web of Science ®Google Scholar
ThorssonLEdsbäckerSKällénAPharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via TurbuhalerBr J Clin Pharmacol200152552953811736861
PubMed Web of Science ®Google Scholar
DalbyCPolanowskiTLarssonTThe bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trialRespir Res20091010419878590
PubMed Web of Science ®Google Scholar
BrattsandRMiller-LarssonAThe role of intracellular esterification in budesonide once-daily dosing and airway selectivityClin Ther200325Suppl CC28C4114642802
PubMed Web of Science ®Google Scholar
EkALarssonKSiljerudSFluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophagesAllergy199954769169910442524
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date